PD-1 Antibodies Healio This activity will review data on the efficacy, safety, and response patterns observed with PD-1 in patients with advanced melanoma. This activity is supported by educational grants from Bristol-Myers Squibb, Delcath Systems, Inc., Merck & Co., Inc ... |
